Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

Use the search and filter options below to find the resources you're looking for.

2223 Resource s
2223 Resource s
    Date
    From
    To
  1. Putting an end to epidemic meningitis in Africa
    This fact sheet describes PATH’s efforts to advance new and better vaccines against meningococcal meningitis and strengthen the global toolkit against this deadly disease. It details work across multiple efforts, including the development and distribution of MenAfriVac®, the vaccine that has virtually eliminated meningitis A wherever it has been introduced; and MenFive®, the groundbreaking multivalent meningococcal conjugate vaccine that has the potential to eliminate epidemic meningitis in Africa, once and for all.
    Published: November 2023
    Resource Page
    Fact Sheet
  2. Frequently asked questions about single dose HPV vaccination
    High–quality evidence assessing single–dose HPV vaccination suggests that implementing a single–dose schedule is scientifically sound and provides the greatest public health benefit.A single–dose HPV vaccination schedule has the potential to reach more girls and avert a greater number of cervical cancer cases than reaching fewer girls with a two–dose regimen.This brief provides a list of frequently asked questions and answers about the evidence around single–dose HPV vaccination, and the current policy landscape.
    Published: November 2023
    Resource Page
    Brief
  3. Frequently asked questions about single dose HPV vaccination
    High–quality evidence assessing single–dose HPV vaccination suggests that implementing a single–dose schedule is scientifically sound, and provides the greatest public health benefit. A single–dose HPV vaccination schedule has the potential to reach more girls and avert a greater number of cervical cancer cases than reaching fewer girls with a two–dose regimen.This brief provides a list of frequently asked questions and answers about the evidence around single–dose HPV vaccination, and the current policy landscape.
    Published: November 2023
    Resource Page
    Brief
  4. Single-Dose HPV Vaccination: Fact sheet on Current Evidence
    The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization concluded that a single dose of human papillomavirus (HPV) vaccine delivers solid protection against HPV. Based on the available evidence, SAGE advised that countries may now choose between a one- or two-dose schedule for 9–14-year-old girls and women aged 15 to 20. This is a major step toward reaching the WHO’s global strategy to accelerate the elimination of cervical cancer.This two-page brief a snapshot of the evidence supporting WHO’s endorsement of a single-dose HPV vaccination schedule.Visit the Single-Dose HPV Vaccine Evaluation Consortium page for additional resources.
    Published: November 2023
    Resource Page
    Brief, Fact Sheet
  5. Supporting a safe and appropriate external ecosystem for self–testing
    PATH actively engages in developing, introducing, and scaling evidence–based self–testing technologies and approaches in low– and middle–income countries. Our comprehensive approach connects research and development efforts with practical deployment interventions, as countries respond to disease and health system challenges by expanding self–testing. We integrate self–test data into digital health systems, facilitate the commercialization of diagnostics tailored to end users, and provide vital support to bolster local primary health care systems.
    Published: October 2023
    Resource Page
    Fact Sheet
Previous
Next